MX2012007660A - Ensayo para anticuerpos contra el virus jc. - Google Patents
Ensayo para anticuerpos contra el virus jc.Info
- Publication number
- MX2012007660A MX2012007660A MX2012007660A MX2012007660A MX2012007660A MX 2012007660 A MX2012007660 A MX 2012007660A MX 2012007660 A MX2012007660 A MX 2012007660A MX 2012007660 A MX2012007660 A MX 2012007660A MX 2012007660 A MX2012007660 A MX 2012007660A
- Authority
- MX
- Mexico
- Prior art keywords
- sample
- subject
- hpvlp
- level
- jcv
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Abstract
La descripción se refiere a los métodos y reactivos para analizar las muestras para la presencia de anticuerpos contra virus JC. Se describe un método que incluye obtener una muestra biológica de un sujeto (por ejemplo, plasma, suero, sangre, orina, o fluido cerebrospinal), contactar la muestra con partículas similares a las virales altamente purificadas (HPVLP) bajo condiciones adecuadas para la unión de un anticuerpo contra JCV en la muestra a un HPVLP, y detectar el nivel del anticuerpo contra JCV en la muestra que se une a HPVLP. En una modalidad, la determinación del nivel de anticuerpos anti-JCV en la muestra del sujeto proporciona un método para identificar el riesgo de en un sujeto.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29404810P | 2010-01-11 | 2010-01-11 | |
US31619310P | 2010-03-22 | 2010-03-22 | |
PCT/US2011/020832 WO2011085369A1 (en) | 2010-01-11 | 2011-01-11 | Assay for jc virus antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012007660A true MX2012007660A (es) | 2012-07-25 |
MX341991B MX341991B (es) | 2016-09-09 |
Family
ID=44305841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012007660A MX341991B (es) | 2010-01-11 | 2011-01-11 | Ensayo para anticuerpos contra el virus jc. |
Country Status (27)
Country | Link |
---|---|
US (2) | US9316641B2 (es) |
EP (3) | EP2524060B1 (es) |
JP (2) | JP5946218B2 (es) |
KR (1) | KR101877576B1 (es) |
CN (1) | CN102906278A (es) |
AU (1) | AU2011203815B2 (es) |
BR (1) | BR112012017014B1 (es) |
CA (1) | CA2784137A1 (es) |
CY (2) | CY1119972T1 (es) |
DK (2) | DK2524060T3 (es) |
ES (2) | ES2664173T3 (es) |
FI (1) | FI3339865T5 (es) |
HK (1) | HK1255318A1 (es) |
HR (2) | HRP20221390T1 (es) |
HU (2) | HUE060312T2 (es) |
IN (1) | IN2012DN06139A (es) |
LT (2) | LT2524060T (es) |
ME (1) | ME03026B (es) |
MX (1) | MX341991B (es) |
NO (1) | NO2524060T3 (es) |
NZ (1) | NZ600681A (es) |
PL (2) | PL2524060T3 (es) |
PT (2) | PT3339865T (es) |
RS (2) | RS63744B1 (es) |
SG (2) | SG181653A1 (es) |
SI (2) | SI2524060T1 (es) |
WO (1) | WO2011085369A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2645106T (pt) | 2005-04-04 | 2017-09-18 | Biogen Ma Inc | Método para avaliar uma resposta imune a um agente terapêutico |
EP3620469A1 (en) | 2006-02-28 | 2020-03-11 | Biogen MA Inc. | Methods of treating inflammatory and autoimmune diseases with natalizumab |
CN101437541A (zh) | 2006-03-03 | 2009-05-20 | 伊兰药品公司 | 用那他珠单抗治疗炎性疾病和自身免疫病的方法 |
AU2010303156B2 (en) | 2009-10-11 | 2016-02-04 | Biogen Ma Inc. | Anti-VLA-4 related assays |
HRP20221390T1 (hr) | 2010-01-11 | 2023-01-06 | Biogen Ma Inc. | Analiza za antitijela jc virusa |
US11287423B2 (en) * | 2010-01-11 | 2022-03-29 | Biogen Ma Inc. | Assay for JC virus antibodies |
RS58967B1 (sr) * | 2011-05-31 | 2019-08-30 | Biogen Ma Inc | Metod evaluacije rizika za pml |
WO2013087601A2 (en) * | 2011-12-12 | 2013-06-20 | Janssen Diagnostics Bvba | Polyomavirus peptide sequences |
EP2839032A4 (en) * | 2012-04-16 | 2015-11-18 | Univ Texas | PROOF OF EXCELLULAR JCV MIRNA |
WO2013192100A1 (en) | 2012-06-18 | 2013-12-27 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods and compositions for detecting jc virus |
US9771413B2 (en) * | 2012-12-31 | 2017-09-26 | Neurimmune Holding Ag | Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases |
US9949671B2 (en) | 2013-03-13 | 2018-04-24 | Orthoaccel Technologies, Inc. | Diagnostic mouthpieces |
US10119976B2 (en) | 2013-05-28 | 2018-11-06 | Biogen Ma Inc. | Method of assessing risk of PML |
EP3757224A3 (en) | 2014-02-27 | 2021-03-17 | Biogen MA Inc. | Method of assessing risk of pml |
MA40985A (fr) | 2014-11-17 | 2017-09-26 | Biogen Ma Inc | Méthodes de traitement de la sclérose en plaques |
IT201600083859A1 (it) * | 2016-08-09 | 2018-02-09 | Univ Degli Studi Di Ferrara | Immunosaggio per l’identificazione di anticorpi contro il virus Polioma JC (JCPyV) mediante l’uso di peptidi sintetici. |
US20210002372A1 (en) * | 2018-03-02 | 2021-01-07 | United States Government As Represented By The Department Of Veterans Affairs | Methods and compositions for treating natalizumab-associated progressive multifocal encephalopathy |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4235601A (en) | 1979-01-12 | 1980-11-25 | Thyroid Diagnostics, Inc. | Test device and method for its use |
US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4517288A (en) | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
US4703017C1 (en) | 1984-02-14 | 2001-12-04 | Becton Dickinson Co | Solid phase assay with visual readout |
CA1291031C (en) | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
US5763262A (en) | 1986-09-18 | 1998-06-09 | Quidel Corporation | Immunodiagnostic device |
DE3856421T2 (de) | 1987-04-27 | 2000-12-14 | Unilever Nv | Spezifische Bindungstestverfahren |
US4943522A (en) | 1987-06-01 | 1990-07-24 | Quidel | Lateral flow, non-bibulous membrane assay protocols |
US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
US4818677A (en) | 1987-12-03 | 1989-04-04 | Monoclonal Antibodies, Inc. | Membrane assay using focused sample application |
AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
US5221616A (en) | 1988-07-15 | 1993-06-22 | Quidel Corporation | Prevention of spontaneous complement activation in mammalian biological fluids |
US5118630A (en) | 1988-11-04 | 1992-06-02 | Quidel Corporation | Method for determining periodic infertility in females |
US6352862B1 (en) | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
US6033665A (en) | 1989-09-27 | 2000-03-07 | Elan Pharmaceuticals, Inc. | Compositions and methods for modulating leukocyte adhesion to brain endothelial cells |
US5084828A (en) | 1989-09-29 | 1992-01-28 | Healthtech Services Corp. | Interactive medication delivery system |
US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
US5096837A (en) | 1990-02-08 | 1992-03-17 | Pacific Biotech, Inc. | Immunochromatographic assay and method of using same |
US5223220A (en) | 1990-03-27 | 1993-06-29 | Pacific Biotech, Inc. | Solid phase immunoassay device and method of making same |
US5118428A (en) | 1990-11-13 | 1992-06-02 | Quidel | Method to remove red blood cells from whole blood samples |
DE4139840B4 (de) | 1990-12-04 | 2005-06-02 | Quidel Corp., San Diego | Antigen-Zubereitung zum Nachweis von H. pylori |
DE69229334T2 (de) | 1991-01-11 | 1999-12-16 | Quidel Corp | Einstufiges querfluss analysenverfahren und ein darin verwendeter nichtsaugfähiger träger |
US5213796A (en) | 1991-05-06 | 1993-05-25 | Dana Farber Cancer Institute | Assay for polyomavirus in humans and uses thereof |
US5225328A (en) | 1991-05-30 | 1993-07-06 | Quidel Corporation | Stable alkaline phosphatase compositions with color enhancement and their use in assays |
US5686315A (en) | 1991-06-14 | 1997-11-11 | Quidel Corporation | Assay device for one step detection of analyte |
EP0646179A4 (en) | 1992-02-04 | 1996-10-02 | Quidel Corp | PROCESS FOR SIMPLIFIED EXTRACTION OF BACTERIAL ANTIGENS USING DEHYDRATE REAGENTS. |
US5541069A (en) | 1992-02-28 | 1996-07-30 | Quidel Corporation | Assay having improved dose response curve |
WO1993018398A1 (en) | 1992-03-10 | 1993-09-16 | Quidel Corporation | Red blood cell separation means for specific binding assays |
CA2153692C (en) | 1993-01-12 | 2011-11-08 | Roy R. Lobb | Recombinant anti-vla4 antibody molecules |
US5415994A (en) | 1993-08-02 | 1995-05-16 | Quidel Corporation | Lateral flow medical diagnostic assay device with sample extraction means |
US5840299A (en) | 1994-01-25 | 1998-11-24 | Athena Neurosciences, Inc. | Humanized antibodies against leukocyte adhesion molecule VLA-4 |
US5434057A (en) | 1994-02-02 | 1995-07-18 | Quidel Corporation | Sperm motility assay and devices |
US5521102A (en) | 1994-08-08 | 1996-05-28 | Quidel Corporation | Controlled sensitivity immunochromatographic assay |
US5845255A (en) | 1994-10-28 | 1998-12-01 | Advanced Health Med-E-Systems Corporation | Prescription management system |
US6551593B1 (en) | 1995-02-10 | 2003-04-22 | Millennium Pharmaceuticals, Inc. | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
US5712172A (en) | 1995-05-18 | 1998-01-27 | Wyntek Diagnostics, Inc. | One step immunochromatographic device and method of use |
US5804452A (en) | 1995-04-27 | 1998-09-08 | Quidel Corporation | One step urine creatinine assays |
US5786220A (en) | 1995-04-28 | 1998-07-28 | Quidel Corporation | Assays and devices for distinguishing between normal and abnormal pregnancy |
US20010051350A1 (en) | 1995-05-02 | 2001-12-13 | Albert Nazareth | Diagnostic detection device and method |
US5773234A (en) | 1995-08-07 | 1998-06-30 | Quidel Corporation | Method and device for chlamydia detection |
DE19543553B4 (de) * | 1995-11-22 | 2009-04-09 | Deutsches Primatenzentrum Gmbh | VP-Antigene des JC-Virus |
US6305377B1 (en) | 1996-12-12 | 2001-10-23 | Michael T. Portwood | System and method for improving compliance of a medical regimen |
US6229011B1 (en) | 1997-08-22 | 2001-05-08 | Hoffman-La Roche Inc. | N-aroylphenylalanine derivative VCAM-1 inhibitors |
US6306642B1 (en) | 1997-11-24 | 2001-10-23 | Quidel Corporation | Enzyme substrate delivery and product registration in one step enzyme immunoassays |
US6623981B2 (en) | 1998-01-27 | 2003-09-23 | Bristol-Myers Squibb Company | Detection of patients at risk for developing integrin antagonist/agonist mediated disease states |
US6014631A (en) | 1998-04-02 | 2000-01-11 | Merck-Medco Managed Care, Llc | Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry |
US6045501A (en) | 1998-08-28 | 2000-04-04 | Celgene Corporation | Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
US6407066B1 (en) | 1999-01-26 | 2002-06-18 | Elan Pharmaceuticals, Inc. | Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
US7171371B2 (en) | 1999-09-03 | 2007-01-30 | Smg Trust | Method and system for providing pre and post operative support and care |
AU1137301A (en) | 1999-10-12 | 2001-04-23 | Connex Gesellschaft Zur Optimierung Von Forschung Und Entwicklung Mbh | Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool |
US6388084B1 (en) | 1999-12-06 | 2002-05-14 | Hoffmann-La Roche Inc. | 4-pyridinyl-n-acyl-l-phenylalanines |
EP2140881B1 (en) | 1999-12-16 | 2013-04-17 | Biogen Idec MA Inc. | Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
EP1271152A4 (en) | 2000-03-30 | 2005-04-27 | Nippon Kayaku Kk | METHOD FOR DETECTING CANCER BY MEASURING AUTOANTIC VIRUSES AGAINST MDM2 AND REAGENTS THEREFOR |
US6620626B1 (en) | 2000-08-09 | 2003-09-16 | Mission Research Corp. | Antigen detection device and method |
MY129000A (en) | 2000-08-31 | 2007-03-30 | Tanabe Seiyaku Co | INHIBITORS OF a4 MEDIATED CELL ADHESION |
DE60135147D1 (de) | 2000-10-17 | 2008-09-11 | Besst Test Aps | Nen biologischen zelle in einer körperflüssigkeitsprobe |
US6315720B1 (en) | 2000-10-23 | 2001-11-13 | Celgene Corporation | Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug |
US6485460B2 (en) | 2001-01-12 | 2002-11-26 | Bracco Diagnostics, Inc. | Tamper evident syringe barrel |
WO2003016902A1 (en) | 2001-08-20 | 2003-02-27 | Proteome Systems Intellectual Property Pty Ltd | Diagnostic testing process and apparatus |
AU2002331408B2 (en) * | 2001-08-20 | 2008-05-08 | Proteome Systems Ltd | Diagnostic testing process and apparatus |
US6605602B1 (en) | 2001-09-28 | 2003-08-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Method of treating BK virus nephropathy |
PT2336184E (pt) | 2002-02-25 | 2015-03-09 | Biogen Idec Inc | Administração de agentes para o tratamento da inflamação |
TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
AU2003243642A1 (en) | 2002-06-21 | 2004-01-06 | Mckesson Automation Inc. | Closed loop medication use system and method |
US20070275481A1 (en) | 2003-11-24 | 2007-11-29 | Biogen Idec Ma Inc. | Methods For Detecting Half-Antibodies Using Chip Based Gel Electophoresis |
JP4672263B2 (ja) | 2004-01-27 | 2011-04-20 | デンカ生研株式会社 | 簡便な検出法、検出装置及び検出キットとその製法 |
US7419666B1 (en) | 2004-02-23 | 2008-09-02 | Massachusetts Eye And Ear Infirmary | Treatment of ocular disorders |
TWI439284B (zh) | 2004-04-09 | 2014-06-01 | Abbvie Biotechnology Ltd | 用於治療TNFα相關失調症之多重可變劑量療法 |
US20050283385A1 (en) | 2004-06-21 | 2005-12-22 | The Permanente Medical Group, Inc. | Individualized healthcare management system |
CN101035563B (zh) | 2004-07-08 | 2012-03-28 | 艾伦药物公司 | 包括聚合物部分的多价vla-4拮抗剂 |
CA2478458A1 (en) | 2004-08-20 | 2006-02-20 | Michael Panzara | Treatment of pediatric multiple sclerosis |
NZ581497A (en) | 2004-12-03 | 2012-07-27 | Biogen Idec Inc | Delaying or preventing onset of multiple sclerosis by vla-4 ginding antibody |
ES2387317T3 (es) | 2005-03-03 | 2012-09-20 | Seedlings Life Science Ventures, Llc. | Procedimiento de control de riesgos de pacientes en tratamiento con natalizumab |
PT2645106T (pt) | 2005-04-04 | 2017-09-18 | Biogen Ma Inc | Método para avaliar uma resposta imune a um agente terapêutico |
CA2624450C (en) | 2005-09-29 | 2014-02-04 | Elan Pharmaceuticals, Inc. | Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
BRPI0708331A2 (pt) | 2006-02-27 | 2011-05-24 | Elan Pharm Inc | compostos de pirimidinil sulfonamida que inibem a adesão leucocitária mediada por vla-4 |
EP3620469A1 (en) | 2006-02-28 | 2020-03-11 | Biogen MA Inc. | Methods of treating inflammatory and autoimmune diseases with natalizumab |
JP2009531304A (ja) | 2006-02-28 | 2009-09-03 | エラン ファーマシューティカルズ,インコーポレイテッド | α−4阻害剤化合物を用いて炎症性疾患および自己免疫疾患を治療する方法 |
CN101437541A (zh) | 2006-03-03 | 2009-05-20 | 伊兰药品公司 | 用那他珠单抗治疗炎性疾病和自身免疫病的方法 |
US7838583B2 (en) * | 2006-06-30 | 2010-11-23 | Sumitomo Rubber Industries, Ltd. | Rubber composition for cap tread and pneumatic tire having cap tread using same |
EP2089515A4 (en) | 2006-11-16 | 2011-02-23 | Novavax Inc | VIRUSUAL PARTICLES OF RESPIRATORY SYNZYTIAL VIRUS |
EP1933140B1 (en) | 2006-12-11 | 2011-08-17 | AraGen Biotechnology Co. Ltd. | Antibody detection method involving an oligonucleotide enhanced collodial gold signal |
CN104316696A (zh) | 2009-02-05 | 2015-01-28 | 生物基因Idecma公司 | 用于检测jc多瘤病毒的方法 |
US9354233B2 (en) | 2009-02-20 | 2016-05-31 | The Regents Of The University Of California | A+ biomarker assays |
HRP20221390T1 (hr) * | 2010-01-11 | 2023-01-06 | Biogen Ma Inc. | Analiza za antitijela jc virusa |
RS58967B1 (sr) | 2011-05-31 | 2019-08-30 | Biogen Ma Inc | Metod evaluacije rizika za pml |
-
2011
- 2011-01-11 HR HRP20221390TT patent/HRP20221390T1/hr unknown
- 2011-01-11 PT PT172031783T patent/PT3339865T/pt unknown
- 2011-01-11 US US13/521,311 patent/US9316641B2/en active Active
- 2011-01-11 RS RS20221053A patent/RS63744B1/sr unknown
- 2011-01-11 SI SI201131438T patent/SI2524060T1/en unknown
- 2011-01-11 EP EP11732315.4A patent/EP2524060B1/en not_active Revoked
- 2011-01-11 FI FIEP17203178.3T patent/FI3339865T5/fi active
- 2011-01-11 WO PCT/US2011/020832 patent/WO2011085369A1/en active Application Filing
- 2011-01-11 SI SI201132069T patent/SI3339865T1/sl unknown
- 2011-01-11 EP EP22191259.5A patent/EP4152004A1/en active Pending
- 2011-01-11 RS RS20180245A patent/RS56977B1/sr unknown
- 2011-01-11 LT LTEP11732315.4T patent/LT2524060T/lt unknown
- 2011-01-11 CA CA2784137A patent/CA2784137A1/en active Pending
- 2011-01-11 PL PL11732315T patent/PL2524060T3/pl unknown
- 2011-01-11 BR BR112012017014-7A patent/BR112012017014B1/pt active IP Right Grant
- 2011-01-11 PT PT117323154T patent/PT2524060T/pt unknown
- 2011-01-11 SG SG2012043154A patent/SG181653A1/en unknown
- 2011-01-11 ME MEP-2018-60A patent/ME03026B/me unknown
- 2011-01-11 ES ES11732315.4T patent/ES2664173T3/es active Active
- 2011-01-11 JP JP2012548227A patent/JP5946218B2/ja active Active
- 2011-01-11 DK DK11732315.4T patent/DK2524060T3/en active
- 2011-01-11 SG SG10201500079YA patent/SG10201500079YA/en unknown
- 2011-01-11 DK DK17203178.3T patent/DK3339865T5/da active
- 2011-01-11 LT LTEP17203178.3T patent/LT3339865T/lt unknown
- 2011-01-11 HU HUE17203178A patent/HUE060312T2/hu unknown
- 2011-01-11 AU AU2011203815A patent/AU2011203815B2/en active Active
- 2011-01-11 PL PL17203178.3T patent/PL3339865T3/pl unknown
- 2011-01-11 ES ES17203178T patent/ES2930469T3/es active Active
- 2011-01-11 CN CN2011800133864A patent/CN102906278A/zh active Pending
- 2011-01-11 IN IN6139DEN2012 patent/IN2012DN06139A/en unknown
- 2011-01-11 EP EP17203178.3A patent/EP3339865B9/en active Active
- 2011-01-11 KR KR1020127019171A patent/KR101877576B1/ko active IP Right Grant
- 2011-01-11 MX MX2012007660A patent/MX341991B/es active IP Right Grant
- 2011-01-11 HU HUE11732315A patent/HUE036183T2/hu unknown
- 2011-01-11 NZ NZ600681A patent/NZ600681A/en unknown
- 2011-01-11 NO NO11732315A patent/NO2524060T3/no unknown
-
2015
- 2015-12-18 JP JP2015246985A patent/JP2016040557A/ja not_active Withdrawn
-
2016
- 2016-03-08 US US15/063,777 patent/US10444234B2/en active Active
-
2018
- 2018-02-27 HR HRP20180356TT patent/HRP20180356T1/hr unknown
- 2018-02-28 CY CY20181100251T patent/CY1119972T1/el unknown
- 2018-11-13 HK HK18114454.0A patent/HK1255318A1/zh unknown
-
2022
- 2022-11-18 CY CY20221100739T patent/CY1126069T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX341991B (es) | Ensayo para anticuerpos contra el virus jc. | |
MX2007014815A (es) | Metodos de inmunoanalisis mejorados. | |
EA201171046A1 (ru) | Зонды и праймеры для детектирования вируса чикунгуньи | |
ATE556030T1 (de) | Ultrasensitiver nachweis von analyten | |
WO2010107654A3 (en) | Split flow device for analyses of specific-binding partners | |
NO20083820L (no) | Deteksjon av kreft ved forhoyede nivaer av BCL-2 | |
IL177693A0 (en) | Method, chip, device and integrated system for detection biological particles | |
RU2014119996A (ru) | Обнаружение, выделение и анализ редких клеток в биологических жидкостях | |
WO2015070037A3 (en) | Polynucleotide conjugates and methods for analyte detection | |
EA200971114A1 (ru) | Определение антигенов, расположенных на эритроцитах, и антиэритроцитарных антител | |
HK1108468A1 (en) | Optoelectronic detection system | |
IN2015DN04062A (es) | ||
WO2009129173A3 (en) | Methods, antibodies and kits for detecting cerebrospinal fluid in a sample | |
WO2007068982A3 (en) | Detection of antibodies | |
MX369610B (es) | Metodos, dispositivos y sistemas para analisis de muestras. | |
WO2012021741A3 (en) | Lateral flow assays for non-diagnostic analytes | |
WO2018172337A8 (en) | IMMUNOASSAY FOR THE DETECTION OF ZIKA VIRUS INFECTION | |
MX2013004207A (es) | Dispositivo de prueba. | |
CY1109461T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου | |
WO2012068107A3 (en) | Autoantibody to rna-protein complex detected by quantitative pcr | |
UA43619U (en) | Method for moprin determination | |
Otieno et al. | Semi-Automated Ultrasensitive Electrochemical Microfluidic Device for Multiplexed Detection of Cancer Protein Biomarkers | |
TH134794B (th) | อุปกรณ์การทำโครมาโตกราฟีทางภูมิคุ้มกัน, วิธีการ และชุดอุปกรณ์ | |
TH120254A (th) | วิธีการสำหรับการทรีทเบื้องต้นตัวอย่างส่งตรวจและวิธีการสำหรับการวิเคราะห์สารทางชีววิทยา | |
TH137052A (th) | ชุดตรวจแบบอิมมูโนโครมาโตกราฟีชนิดการไหลด้านข้างสำหรับหาโมเลกุลเป้าหมาย |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Change of company name or juridical status |
Owner name: MICROSOFT TECHNOLOGY LICENSING, LLC |
|
FG | Grant or registration |